-
Hot Stock List: ImmunoCellular Therapeutics, (NYSEMKT:IMUC), Verizon Communications Inc. (NYSE:VZ), Zhaopin (NYSE:ZPIN), Medtronic plc (NYSE:MDT), Calix Inc. (NYSE:CALX)
On Friday shares of ImmunoCellular Therapeutics, Ltd. (NYSEMKT:IMUC) closed at $0.48. On May 11, ImmunoCellular Therapeutics, Ltd. (NYSEMKT:IMUC) announced financial results for the first quarter 2015. For the quarter ended March 31, 2015, the Company reported a net loss of $1.4 million, or $0.02 per basic and diluted share, compared to a net loss of…
-
Active Stocks: TRW Automotive Holdings Corp. (NYSE:TRW), ImmunoCellular Therapeutics, (NYSEMKT:IMUC), United Microelectronics Corporation (NYSE:UMC), BlackRock Kelso (NASDAQ:BKCC), Hudson Pacific Properties (NYSE:HPP)
On Thursday shares of TRW Automotive Holdings Corp. (NYSE:TRW) closed at $105.46. Company’s sales growth for last 5 years was 8.60% and EPS growth for next 5 years is recorded as 4.05%. On May 5, TRW Automotive Holdings Corp. (NYSE:TRW), reported first quarter 2015 financial results with sales of $4.1 billion, an increase of 7%…
-
Stocks in News: Contango Oil & Gas Company (NYSEMKT:MCF), Tantech Holdings Ltd (NASDAQ:TANH), ImmunoCellular Therapeutics, (NYSEMKT:IMUCN),evsun Resources (NYSEMKT:NSU), Ariad Pharmaceuticals (NASDAQ:ARIA)
On Friday shares of Contango Oil & Gas Company (NYSEMKT:MCF) closed at $20.88. Contango Oil & Gas Company (NYSE MKT: MCF) announced it expects to issue its first quarter 2015 earnings press release, including an operational update, before the market opens on Monday, May 11, 2015. In conjunction with the release, Contango will conduct a…
-
Why Making Dramatic Moves: OncoGenex Pharmaceuticals (NASDAQ:OGXI), ImmunoCellular Therapeutics, (NYSEMKT:IMUC), Progenics Pharmaceuticals (NASDAQ:PGNX), Keurig Green Mountain (NASDAQ:GMCR), Eastman Chemical (NYSE:EMN)
On Friday shares of OncoGenex Pharmaceuticals, Inc. (NASDAQ:OGXI) closed at $1.90. Company’s sales growth for last 5 years was 1.20%. OncoGenex Pharmaceuticals, Inc. (NASDAQ:OGXI) announced that it will report its first quarter 2015 financial results on Thursday, May 14, 2015. ImmunoCellular Therapeutics, Ltd. (NYSEMKT:IMUC) in last trading activity advanced 1.09% to close at $0.46. Company…
-
Trader’s Recap: Weatherford International (NYSE:WFT), Twenty-First Century Fox (NASDAQ:FOXA), CNB Financial Corp. (NASDAQ:CCNE), ImmunoCellular Therapeutics, (NYSEMKT:IMUC), China Distance Education (NYSE:DL)
On Tuesday shares of Weatherford International plc (NYSE:WFT) closed at $14.41. Company’s sales growth for last 5 years was 11.00% and EPS growth for next 5 years is recorded as 10.93%. Weatherford International plc (NYSE:WFT) has announced commercial release of its SecureView wireline cased-hole evaluation suite. As managing well integrity has become more critical across…
-
Market Movers: ImmunoCellular Therapeutics, (NYSEMKT:IMUC), Caterpillar Inc. (NYSE:CAT), Cascade Microtech Inc. (NASDAQ:CSCD), Anacor Pharmaceuticals (NASDAQ:ANAC), IF Bancorp (NASDAQ:IROQ)
On Thursday shares of ImmunoCellular Therapeutics, Ltd. (NYSEMKT:IMUC) closed at $0.46. ImmunoCellular Therapeutics, Ltd. (NYSEMKT:IMUC) announced that it plans to report financial results for the first quarter 2015 on Monday, May 11, 2015. On last trading day Caterpillar Inc. (NYSE:CAT) decreased -0.71% to close at $86.88. Its volatility for the week is 1.87% while volatility…
-
Top Wall Street Stories: ImmunoCellular Therapeutics, (NYSEMKT:IMUC), Zynga Inc (NASDAQ:ZNGA), Ruby Tuesday (NYSE:RT), Biogen Inc. (NASDAQ:BIIB), Ford Motor Company (NYSE:F)
On Friday shares of ImmunoCellular Therapeutics, Ltd. (NYSEMKT:IMUC) closed at $0.44. Equities research analysts at Roth Capital started coverage on shares of ImmunoCellular Therapeutics, Ltd. (NYSEMKT:IMUC) in a research note issued to investors on Friday. The firm set a “buy” rating and a $3.00 price target on the stock. Roth Capital’s price target would suggest…
-
Morning Alert: Merrimack Pharmaceuticals (NASDAQ:MACK), Visa Inc. (NYSE:V), Dipexium Pharmaceuticals (NASDAQ:DPRX), ImmunoCellular Therapeutics, (NYSEMKT:IMUC)
On Monday shares of Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) closed at $11.87. Company’s sales growth for last 5 years was 117.70% and EPS growth for next 5 years is recorded as 5.60%. Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) announced that it will present preclinical and clinical data showcasing its deep oncology pipeline at the 2015 American Association for…
-
Today’s Hot List: Oasis Petroleum Inc. (NYSE:OAS), ImmunoCellular Therapeutics (NYSEMKT:IMUC), JPMorgan Chase (NYSE:JPM), Popeyes Louisiana Kitchen (NASDAQ:PLKI), Gol Linhas Aereas Inteligentes (NYSE:GOL)
On Tuesday shares of Oasis Petroleum Inc. (NYSE:OAS) closed at $13.05. Company’s sales growth for last 5 years was 105.60%. SunTrust upgraded shares of Oasis Petroleum (NYSE:OAS)from a reduce rating to a neutral rating in a report released on Monday, TheFlyOnTheWall.com reports. ImmunoCellular Therapeutics, Ltd. (NYSEMKT:IMUC) in last trading activity moved up 0.25% to close…
-
Watch 5 Stocks: ImmunoCellular Therapeutics, (NYSEMKT:IMUC), Energous Corporation (NASDAQ:WATT), Cumberland Pharmaceuticals (NASDAQ:CPIX), Delta Air Lines (NYSE:DAL), Merck & Co. (NYSE:MRK)
ImmunoCellular Therapeutics, Ltd. (NYSEMKT:IMUC) announced financial results for the fourth quarter and year ended December 31, 2014. For the year ended December 31, 2014, ImmunoCellular incurred a net loss of $9.4 million, or $0.16 per basic and diluted share, compared to a net loss of $8.8 million, or $0.16 per basic and diluted share, for…